H. Murakoshi

发表

Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals

S. Matsushita, T. Takemura, T. Yamashiro, 2020, Journal of Virology.

Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection

G. Learn, B. Haynes, I. Williams, 2019, Proceedings of the National Academy of Sciences.

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control

S. Rowland-Jones, S. Oka, M. Koyanagi, 2018, EBioMedicine.

Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8+ T Cells and Accumulation of HLA-Associated Escape Mutations

S. Oka, H. Gatanaga, M. Takiguchi, 2020, Journal of Virology.

Critical effect of Pol escape mutations associated with detrimental allele HLA-C∗15:05 on clinical outcome in HIV-1 subtype A/E infection

M. Takiguchi, T. Chikata, N. Kuse, 2020, AIDS.

Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses

S. Oka, M. Koyanagi, H. Gatanaga, 2016, Journal of Virology.

Different In Vivo Effects of HIV-1 Immunodominant Epitope-Speciﬁc Cytotoxic T Lymphocytes on Selection of Escape Mutant Viruses (cid:1) ‡

S. Oka, M. Hashimoto, A. Hachiya, 2010 .

Molecular phylogeny and diversity of Myanmar and Bhutan mithun based on mtDNA sequences.

Kazuaki Tanaka, T. Takizawa, H. Murakoshi, 2011, Animal science journal = Nihon chikusan Gakkaiho.

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele

S. Oka, H. Gatanaga, M. Takiguchi, 2022, Journal of virology.

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele

S. Oka, H. Gatanaga, M. Takiguchi, 2022, Journal of virology.

Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication

S. Oka, H. Gatanaga, M. Takiguchi, 2018, Journal of Virology.

Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya

Y. S. Mohamed, C. Brander, W. Jaoko, 2020, Vaccines.

A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection

J. Carlson, S. Oka, Z. Brumme, 2016, AIDS.

Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.

W. Sugiura, S. Oka, H. Ode, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Host-Specific Adaptation of HIV-1 Subtype B in the Japanese Population

M. John, S. Mallal, J. Carlson, 2014, Journal of Virology.

Selection of escape mutant by HLA‐C‐restricted HIV‐1 Pol‐specific cytotoxic T lymphocytes carrying strong ability to suppress HIV‐1 replication

S. Oka, M. Koyanagi, M. Hashimoto, 2011, European journal of immunology.

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics

S. Oka, Z. Brumme, C. Brumme, 2020, PLoS pathogens.

Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.

S. Oka, Koji Watanabe, M. Koyanagi, 2013, Microbes and infection.

Selection of HLA-B57-associated Gag A146P mutant by HLA-B∗48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese.

S. Oka, M. Koyanagi, H. Gatanaga, 2011, Microbes and infection.

HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E

M. Carrington, Y. Qi, S. Oka, 2017, Journal of Virology.

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes

S. Oka, M. Koyanagi, H. Gatanaga, 2015, Journal of Virology.

Control of HIV-1 by an HLA-B*52: 01-C*12 02 Protective Haplotype

S. Oka, M. Koyanagi, H. Gatanaga, 2017, The Journal of infectious diseases.

[Control of HIV infection and selection/ accumulation of HIV escape mutants by HIV-specific cytotoxic T lymphocytes (CTLs)].

M. Takiguchi, H. Murakoshi, 2013, Uirusu.

Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity

M. John, S. Mallal, N. Pfeifer, 2012, Journal of Virology.

Different In Vivo Effects of HIV-1 Immunodominant Epitope-Specific Cytotoxic T Lymphocytes on Selection of Escape Mutant Viruses

S. Oka, M. Hashimoto, A. Hachiya, 2010, Journal of Virology.

Different in vivo effects of HIV-1 immunodominant epitope-specific CTLs on selection of escape mutant viruses

S. Oka, M. Hashimoto, A. Hachiya, 2010 .

Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801.

S. Oka, M. Takiguchi, T. Akahoshi, 2009, Human immunology.

HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03.

M. Carrington, Y. Qi, S. Oka, 2016, Cell reports.

Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes

S. Rowland-Jones, S. Oka, H. Gatanaga, 2021, Journal of virology.

Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection

S. Oka, M. Takiguchi, T. Chikata, 2022, Journal of virology.

Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines

C. Brander, T. Hanke, A. Llano, 2017, PloS one.

Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach

P. Borrow, S. Oka, Wayne Paes, 2019, Journal of Virology.

Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1

S. Oka, H. Gatanaga, M. Takiguchi, 2020, Journal of Virology.

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

A. McMichael, S. Oka, Bette Korber, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Identification of novel HIV-1-derived HLA-E-binding peptides

A. McMichael, S. Brackenridge, T. Hanke, 2018, Immunology letters.

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens

S. Oka, T. Hanke, H. Gatanaga, 2019, Journal of Virology.

CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication

S. Oka, T. Hanke, H. Gatanaga, 2018, Retrovirology.

Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition.

S. Oka, H. Gatanaga, M. Takiguchi, 2014, Microbes and infection.

Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells.

S. Oka, M. Koyanagi, H. Gatanaga, 2011, Microbes and infection.

Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections

S. Oka, M. Koyanagi, H. Gatanaga, 2015, Journal of Virology.

CTL recognition of HIV‐1‐infected cells via cross‐recognition of multiple overlapping peptides from a single 11‐mer Pol sequence

S. Oka, M. Hashimoto, M. Takiguchi, 2012, European journal of immunology.